CART (Chimeric Antigen Receptor T-cell) therapy

CART therapy is a type of immunotherapy that uses genetically modified T-cells, a key component of the immune system, to fight cancer. In this process, a patient's T-cells are collected and engineered in the lab to produce special receptors called CARs, which recognize and attack cancer cells. These modified cells are then multiplied and infused back into the patient, where they seek out and destroy cancer cells more effectively. CART therapy has shown promising results, especially in certain blood cancers like leukemia and lymphoma, by harnessing and enhancing the body's natural immune response.